To investigate the effect of locally applied nimodipine prolonged-release microparticles on angiographic vasospasm and secondary brain injury after experimental subarachnoid hemorrhage (SAH).70 male Wistar rats were categorized into three groups: 1) sham operated animals (control), 2) animals with SAH only (control) and the 3) treatment group. SAH was induced using the double hemorrhage model. The treatment group received different concentrations (20%, 30% or 40%) of nimodipine microparticles. Angiographic vasospasm was assessed 5 days later using digital subtraction angiography (DSA). Histological analysis of frozen sections was performed using H&E-staining as well as Iba1 and MAP2 immunohistochemistry.DSA images were sufficient for assess...
Background: Cerebral vasospasm is a major cause of morbidity and mortality after subarachnoid hemorr...
Background and Purpose- EG-1962 is a sustained release formulation of nimodipine administered via ex...
Object The calcium antagonist nimodipine has been shown to reduce the incidence of ischemic complica...
To investigate the effect of locally applied nimodipine prolonged-release microparticles on angiogra...
Background and Purpose: To investigate the effect of locally applied nimodipine prolonged-release mi...
Nimodipine improved outcome in patients with subarachnoid hemorrhage (SAH) although hypotension limi...
(SAH) has been a serious clinical problem. The aim of the present study is to evaluate the efficacy ...
Copyright © 2015 Janne Koskimäki et al. This is an open access article distributed under the Creati...
We investigated the effect of ebselen relative to nimodipine in an animal model of subarachnoid hemo...
Nimodipine is a widely used medication for treating delayed cerebral ischemia (DCI) after subarachno...
BACKGROUND: Oral nimodipine is an established prophylactic agent for cerebral vasospasm after subara...
SUMMARY Experimental subarachnoid hemorrhage (SAH) was induced in baboons by repeated injec-tions of...
none6noIntra-arterial Nimodipine administration can be an effective alternative to papaverine or bal...
OBJECTIVE: Despite dramatic advances in all medical era, cerebral vasospasm is still the major compl...
Aim:Subarachnoid hemorrhage (SAH) is a devastating disease, resulting in imparting long-term cogniti...
Background: Cerebral vasospasm is a major cause of morbidity and mortality after subarachnoid hemorr...
Background and Purpose- EG-1962 is a sustained release formulation of nimodipine administered via ex...
Object The calcium antagonist nimodipine has been shown to reduce the incidence of ischemic complica...
To investigate the effect of locally applied nimodipine prolonged-release microparticles on angiogra...
Background and Purpose: To investigate the effect of locally applied nimodipine prolonged-release mi...
Nimodipine improved outcome in patients with subarachnoid hemorrhage (SAH) although hypotension limi...
(SAH) has been a serious clinical problem. The aim of the present study is to evaluate the efficacy ...
Copyright © 2015 Janne Koskimäki et al. This is an open access article distributed under the Creati...
We investigated the effect of ebselen relative to nimodipine in an animal model of subarachnoid hemo...
Nimodipine is a widely used medication for treating delayed cerebral ischemia (DCI) after subarachno...
BACKGROUND: Oral nimodipine is an established prophylactic agent for cerebral vasospasm after subara...
SUMMARY Experimental subarachnoid hemorrhage (SAH) was induced in baboons by repeated injec-tions of...
none6noIntra-arterial Nimodipine administration can be an effective alternative to papaverine or bal...
OBJECTIVE: Despite dramatic advances in all medical era, cerebral vasospasm is still the major compl...
Aim:Subarachnoid hemorrhage (SAH) is a devastating disease, resulting in imparting long-term cogniti...
Background: Cerebral vasospasm is a major cause of morbidity and mortality after subarachnoid hemorr...
Background and Purpose- EG-1962 is a sustained release formulation of nimodipine administered via ex...
Object The calcium antagonist nimodipine has been shown to reduce the incidence of ischemic complica...